Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.7435 |
---|---|
High | 0.7435 |
Low | 0.7425 |
Bid | 0.759 |
Offer | 0.81 |
Previous close | 0.7525 |
Average volume | 0.00 |
---|---|
Shares outstanding | 285.54m |
Free float | 256.49m |
P/E (TTM) | -- |
Market cap | 242.71m USD |
EPS (TTM) | -0.5407 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 08:30 BST.
More ▼
Press releases
- Precigen to Participate in the 2024 Cantor Global Healthcare Conference
- Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
- Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th
- Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock
- Precigen Announces Proposed $30 Million Public Offering of Common Stock
- Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch
- Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch
More ▼